Insights & Resources
Perspectives, reports, and research from the Atacana team built for the senior leaders navigating the most complex commercial decisions in the industry.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Explore Our Content
Competitive Readiness
Atacana Group
•
June 23, 2023
How to anticipate competitor market access & penetration strategy across multiple markets and differentiate through targeted efforts in an underdeveloped therapeutic area?
Case Studies
Strategy
Exploration for Portfolio Expansion and Product Acquisition
Atacana Group
•
June 7, 2023
Identify the next blockbuster opportunity for our partner – both in MoA and potential indications
Case Studies
Strategy
Pharma Service Benchmarking
Atacana Group
•
June 1, 2023
Blockbuster legacy drugs were elevating long-term safety data concerns in advance of our partner company’s drug launch.
Case Studies
Strategy
Migraine Key Catalysts for 2023
Atacana Group
•
June 1, 2023
While there is no cure for migraine, pharmaceutical companies continue to innovate to provide treatment options for patients suffering from migraine.
Reports
Neuroscience
Novel and Emerging Treatments in Spinal Muscular Atrophy
Atacana Group
•
June 1, 2023
Marketed products are being evaluated for age expansion, dose increase, and in previously treated SMA patients
Reports
Neuroscience
Rare Diseases
.avif)